Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 585917, 21 pages
http://dx.doi.org/10.1155/2015/585917
Review Article

Association between Genetic Variants and Diabetes Mellitus in Iranian Populations: A Systematic Review of Observational Studies

1Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
2Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Received 16 October 2014; Accepted 15 January 2015

Academic Editor: Aziz Ghahary

Copyright © 2015 Mehrnoosh Khodaeian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 27, Supplement 1, pp. S5–S10, 2004. View at Publisher · View at Google Scholar
  2. World Health Organization (WHO), Diabetes Mellitus, Report of a WHO Expert Committee, WHO Technical Report Series no. 310, World Health Organization, Geneva, Switzerland, 1965.
  3. World Health Organization (WHO), “WHO expert committee on diabetes mellitus,” WHO Technical Report Series No. 646, World Health Organization (WHO), Geneva, Switzerland, 1980. View at Google Scholar
  4. International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, 6th edition, 2013, http://www.idf.org/diabetesatlas.
  5. F. Najafipoor, F. Azizi, and M. Zareizadeh, “Epidemiologic investigation of familial type 2 diabetes in Tehran,” Iranian Journal of Diabetes and Lipid Disorders, vol. 4, no. 1, pp. 35–42, 2004. View at Google Scholar
  6. IDF Diabetes Atlas, New Estimates for 2012 of Diabetes Prevalence, Mortality, and Healthcare Expenditures, 5th edition, 2012, http://www.idf.org/.
  7. A. A. Haghdoost, M. Rezazadeh-Kermani, B. Sadghirad, and H. R. Baradaran, “Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis,” Eastern Mediterranean Health Journal, vol. 15, no. 3, pp. 591–599, 2009. View at Google Scholar · View at Scopus
  8. S. M. Akrami, “Genetic counseling in diabetes,” Iranian Journal of Diabetes and Lipid Disorders, vol. 6, no. 3, pp. 205–213, 2007. View at Google Scholar · View at Scopus
  9. National Diabetes Data Group, “Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance,” Diabetes, vol. 28, no. 12, pp. 1039–1057, 1979. View at Publisher · View at Google Scholar
  10. K. Xiang, Y. Wang, T. Zheng et al., “Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese,” Diabetes, vol. 59, pp. 228–234, 2004. View at Google Scholar
  11. T. H. Luo, Y. Zhao, G. Li et al., “A genome-wide search for type II diabetes susceptibility genes in Chinese Hans,” Diabetologia, vol. 44, no. 4, pp. 501–506, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Ali, “Genetics of type 2 diabetes,” World Journal of Diabetes, vol. 4, no. 4, pp. 114–123, 2013. View at Publisher · View at Google Scholar
  13. I. Prokopenko, M. I. McCarthy, and C. M. Lindgren, “Type 2 diabetes: new genes, new understanding,” Trends in Genetics, vol. 24, no. 12, pp. 613–621, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Abbas, S. T. Raza, F. Ahmed, A. Ahmad, S. Rizvi, and F. Mahdi, “Association of genetic polymorphism of PPARγ-2, ACE, MTHFR, FABP-2 and FTO genes in risk prediction of type 2 diabetes mellitus,” Journal of Biomedical Science, vol. 20, no. 1, pp. 80–88, 2013. View at Google Scholar
  15. Q.-Y. Huang, M.-R. Cheng, and S.-L. Ji, “Linkage and association studies of the susceptibility genes for type 2 diabetes,” Acta Genetica Sinica, vol. 33, no. 7, pp. 573–589, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Li, H. J. Shin, E. L. Ding, and R. M. van Dam, “Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis,” The Journal of the American Medical Association, vol. 302, no. 2, pp. 179–188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Bakhtiari, A. Babakhani, M. H. Maleki et al., “Investigation of the association between rs2970847 polymorphism of PGC-1α gene and type 2 diabetes mellitus, a systematic review and meta analysis,” Journal of Research of Medical School of Shahid Beheshti University, vol. 36, pp. 104–110, 2012. View at Google Scholar
  18. H. Ounissi-Benkalha and C. Polychronakos, “The molecular genetics of type 1 diabetes: new genes and emerging mechanisms,” Trends in Molecular Medicine, vol. 14, no. 6, pp. 268–275, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” British Medical Journal, vol. 339, Article ID b2535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. World Health Organization (WHO), “Definition and diagnosis of diabetes mellitusand intermediate hyperglycemia,” Report of a WHO/IDF Consultation, 2006. View at Google Scholar
  21. J. P. Vandenbroucke, E. von Elm, D. G. Altman et al., “Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration,” PLoS Medicine, vol. 4, no. 10, article e297, 2007. View at Publisher · View at Google Scholar
  22. S. Ahmadi, J. Rostamzadeh, D. Khosravi, P. Shariati, and N. Shakiba, “Association of CTLA-4 gene 49A/G polymorphism with the incidence of type 1 diabetes mellitus in the Iranian Kurdish population,” Pakistan Journal of Biological Sciences, vol. 16, no. 24, pp. 1929–1935, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. Karamizadeh, E. Kamali Sarvestani, F. Saki et al., “Investigation of osteopontin levels and genomic variation of osteopontin and its receptors in type 1 diabetes mellitus,” Journal of Endocrinological Investigation, vol. 36, no. 11, pp. 1090–1093, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Rahbani-Nabar, A. Rezaie, S. Bazzaz, and N. A. Zadeh, “Association of 137 polymorphism in the interleukin-18 gene promoter with diabetes melhitus type 1 in East Azerbaijan population,” Medical Journal of Tabriz University of Medical Sciences and Health Services, vol. 35, no. 2, pp. 38–43, 2013. View at Google Scholar
  25. S. Bonakdaran, M. R. Abbaszadegan, E. Dadkhah, and M. Khajeh-Dalouie, “Vitamin D receptor gene polymorphisms in type 1 diabetes mellitus: a new pattern from Khorasan province, Islamic Republic of Iran,” Eastern Mediterranean Health Journal, vol. 18, no. 6, pp. 614–619, 2012. View at Google Scholar · View at Scopus
  26. Z. Mohammadnejad, M. Ghanbari, R. Ganjali et al., “Association between vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in Iranian population,” Molecular Biology Reports, vol. 39, no. 2, pp. 831–837, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. J. T. Afshari, S. M. Taghavi, S. S. Fatemi, H. Rafatpanah, F. Gheybi, and N. Nezamdoost, “TAP2 polymorphisms in Iranian patients with type I diabetes mellitus,” International Journal of Genetics and Molecular Biology, vol. 3, no. 8, pp. 115–119, 2011. View at Google Scholar · View at Scopus
  28. A. Massoud, N. Sheikh Bahai, M. Massoud et al., “IL18 gene polymorphism in type I diabetic patients: a case-control study,” Tehran University Medical Journal, vol. 67, no. 1, pp. 20–24, 2009. View at Google Scholar · View at Scopus
  29. M. Masood, I. Salehi, N. Sheykh Bahayi, M. Vojgani, A. A. Rajab, and A. Massoud, “Investigation of codon 25 polymorphism of TGFβ gene in type I diabetes mellitus patients,” Journal of Medical Faculty Guilan University of Medical Sciences, vol. 16, no. 62, pp. 1–6, 2007. View at Google Scholar
  30. A. H. Masoud, A. Keihani, N. Sheykhbahaee et al., “Investigation of polymorphism of IL-12 in type I diabetes mellitus patients,” Medical Journal of Mashhad University of Medical Sciences, vol. 50, no. 97, pp. 283–286, 2007. View at Google Scholar
  31. Z. Mojtahedi, S. Naeimi, S. Farjadian, G. R. Omrani, and A. Ghaderi, “Association of IL-18 promoter polymorphisms with predisposition to Type 1 diabetes,” Diabetic Medicine, vol. 23, no. 3, pp. 235–239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. Z. Mojtahedi, G. R. Omrani, M. Doroudchi, and A. Ghaderi, “CTLA-4 +49 A/G polymorphism is associated with predisposition to type 1 diabetes in Iranians,” Diabetes Research and Clinical Practice, vol. 68, no. 2, pp. 111–116, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Zamani, M. A. Tabatabaiefar, A. S. Esfahani, F. Mostafavi, A. Sotoudeh, and B. Larijani, “Correlation between the CD4 gene polymorphism with type 1 diabetes mellitus in the Iranian population,” Iranian Journal of Diabetes and Lipid Disorders, vol. 4, no. 4, pp. 1–9, 2005. View at Google Scholar · View at Scopus
  34. S. M. Taghavi, S. S. Fatemi, H. Rafatpanah, R. Ganjali, J. Tavakolafshari, and N. Valizadeh, “Mutations in the coding regions of the hepatocyte nuclear factor 4 alpha in Iranian families with maturity onset diabetes of the young,” Cardiovascular Diabetology, vol. 8, article 63, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. A. A. Amiri, M. B. Hashemi-Soteh, M. R. Haghshenas, F. Daneshvar, A. Rastegar, and T. Farazmand, “Haptoglobin polymorphism in individuals with type 2 diabetic microangiopathy,” North American Journal of Medical Sciences, vol. 5, no. 9, pp. 529–535, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Andalib, G. Vaseghi, A. Motavallian et al., “Association of polymorphism of ser311cys paraoxonase-2 gene with type 2 diabetes mellitus in Iran,” International Journal of Preventive Medicine, vol. 4, no. 5, pp. 517–522, 2013. View at Google Scholar · View at Scopus
  37. L. Kohan, M. Nasiri, A. Habib, and A. Bolhasani, “Association of G-2548A polymorphism in the promoter of leptin gene with plasma leptin level and risk of type 2 diabetes,” Journal of Shahid Sadoughi University of Medical Sciences, vol. 21, no. 1, pp. 70–77, 2013. View at Google Scholar
  38. F. M. Alami, N. M. Samaei, M. Ahmadi et al., “Association of transcription factor 7-like 2 (Tcf7l2) gene haplotypes with the risk of type 2 diabetes mellitus in Iran,” Advances in Biological Research, vol. 7, no. 5, pp. 145–150, 2013. View at Google Scholar
  39. S. Mahmazi, K. Parivar, M. Rahnema, and M. Ohadi, “Calreticulin novel mutations in type 2 diabetes mellitus,” International Journal of Diabetes in Developing Countries, vol. 33, no. 4, pp. 219–225, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Mohammadi, M. Pourahmadi, M. Mosalanejad, H. Jamali, M. A. Ghobadifar, and S. Erfanian, “Association of estrogen receptor α genes PvuII and XbaI polymorphisms with type 2 diabetes mellitus in the inpatient population of a hospital in Southern Iran,” Diabetes and Metabolism Journal, vol. 37, no. 4, pp. 270–277, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Motavallian, S. Andalib, G. Vaseghi, H. Mirmohammad-Sadeghi, and M. Amini, “Association between PRO12ALA polymorphism of the PPAR-γ2 gene and type 2 diabetes mellitus in Iranian patients,” Indian Journal of Human Genetics, vol. 19, no. 2, pp. 239–244, 2013. View at Publisher · View at Google Scholar
  42. S. Sepahi, R. Jalal, B. Toluinia, A. Asoodeh, and J. Darvish, “Evaluation of relationship between HNF-1α and GLP-1R polymorphisms and type 2 diabetes in a population living in northeast of Iran,” Journal of Cell and Molecular Research, vol. 5, no. 2, pp. 54–59, 2013. View at Google Scholar
  43. M. H. Sheikhha, M. Afkhami-Ardekani, S. M. R. Mirjalili, S. M. R. Dehghani, and H. R. Ghadimi, “Investigating the frequency of MSPI polymorphism of APOA1 gene in type II diabetic patients and comparing it with this frequency in nondiabetics,” Genetics in the 3rd Millennium, vol. 11, no. 2, pp. 3078–3083, 2013. View at Google Scholar
  44. H. Yaghoubi, M. Haghi, and S. Solhi, “Detection of CXCL5 gene polymorphism with diabetes in Ardabil province,” Journal of Ardabil University of Medical Sciences, vol. 13, no. 4, pp. 438–443, 2013. View at Google Scholar
  45. F. Bahreini, S. M. M. Ardebili, S. Farajnia et al., “A study on association of SNP-43 polymorphism in Calpain-10 gene with type 2 diabetes mellitus in the population of Eastern Azerbaijan province,” Iranian South Medical of Journal, vol. 15, no. 1, pp. 35–41, 2012. View at Google Scholar
  46. R. Derakhshan, M. K. Arababadi, Z. Ahmadi et al., “Increased circulating levels of SDF-1 (CXCL12) in type 2 diabetic patients are correlated to disease state but are unrelated to polymorphism of the SDF-1β gene in the Iranian population,” Inflammation, vol. 35, no. 3, pp. 900–904, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Haghani and S. Bakhtiyari, “The study on the relationship between IRS-1 Gly972Arg and IRS-2 Gly1057Asp polymorphisms and type 2 diabetes in the Kurdish ethnic group in west Iran,” Genetic Testing and Molecular Biomarkers, vol. 16, no. 11, pp. 1270–1276, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. F. M. Alami, M. Ahmadi, H. Bazrafshan et al., “Association of the TCF7L2 rs12255372 (G/T) variant with type 2 diabetes mellitus in an Iranian population,” Genetics and Molecular Biology, vol. 35, no. 2, pp. 413–417, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Meshkani, H. Saberi, N. Mohammadtaghvaei, and M. A. Tabatabaiefar, “Estrogen receptor alpha gene polymorphisms are associated with type 2 diabetes and fasting glucose in male subjects,” Molecular and Cellular Biochemistry, vol. 359, no. 1-2, pp. 225–233, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. E. Moasser, S. R. Kazemi-Nezhad, M. Saadat, and N. Azarpira, “Study of the association between glutathione S-transferase (GSTM1, GSTT1, GSTP1) polymorphisms with type II diabetes mellitus in southern of Iran,” Molecular Biology Reports, vol. 39, no. 12, pp. 10187–10192, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. S. M. Mohaddes, F. Karami, J. Gharesouran, and A. Bahrami, “The soluble carrier 30 A8 (SLC30A8) gene polymorphism and risk of Diabetes Mellitus Type 2 in Eastern Azerbijan population of Iran,” Journal of Sciences, Islamic Republic of Iran, vol. 23, no. 1, pp. 15–20, 2012. View at Google Scholar · View at Scopus
  52. M. R. Oladi, J. Behravan, M. Hassani et al., “Glucokinase gene promoter-30G>A polymorphism: a cross-sectional association study with obesity, diabetes Mellitus, hyperlipidemia, hypertension and metabolic syndrome in an Iranian hospital,” Revista de Nutricao, vol. 25, no. 4, pp. 487–495, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Palizban, M. Nikpour, R. Salehi, and M.-R. Maracy, “Association of a common variant in TCF7L2 gene with type 2 diabetes mellitus in a Persian population,” Clinical and Experimental Medicine, vol. 12, no. 2, pp. 115–119, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. O. Tabatabaei-Malazy, H. Fakhrzadeh, M. Qorbani et al., “Apolipoprotein E gene polymorphism and its effect on anthropometric measures in normoglycemic subjects and type 2 diabetes,” Journal of Diabetes & Metabolic Disorders, vol. 11, article 18, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Ghasemi, R. Habibipour, and P. Keshavarz, “The association study of the E23k Kcnj11 variant with progression of type 2 diabetes among obese individuals in a population in the North of Iran,” Iranian Journal of Endocrinology and Metabolism, vol. 13, supplement 6, pp. S673–S680, 2012. View at Google Scholar
  56. S. H. Ranjbar, M. M. Amoli, M. Sajadi et al., “Genetic association analysis of the adiponectin polymorphisms in type 2 diabetes with and without complications,” Iranian Journal of Diabetes and Lipid Disorders, vol. 10, pp. 1–4, 2011. View at Google Scholar · View at Scopus
  57. M. Mehrab-Mohseni, O. Tabatabaei-Malazy, S. Hasani-Ranjbar et al., “Endothelial nitric oxide synthase VNTR (intron 4 a/b) polymorphism association with type 2 diabetes and its chronic complications,” Diabetes Research and Clinical Practice, vol. 91, no. 3, pp. 348–352, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. R. Nosratabadi, M. K. Arababadi, and V. A. Salehabad, “Vitamin D receptor polymorphisms in type 2 diabetes in southeastern Iranian patients,” Laboratory Medicine, vol. 42, no. 1, pp. 32–34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Saberi, N. Mohammadtaghvaei, S. Gulkho et al., “The ENPP1 K121Q polymorphism is not associated with type 2 diabetes and related metabolic traits in an Iranian population,” Molecular and Cellular Biochemistry, vol. 350, no. 1-2, pp. 113–118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Fallah, M. Jafarzadeh, and M. Hedayati, “No association of the SUMO4 polymorphism M55V variant in type 2 diabetes in Iranian subjects,” Diabetes Research and Clinical Practice, vol. 90, no. 2, pp. 191–195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Heidari, S. M. Akrami, R. Heshmat, P. Amiri, H. Fakhrzadeh, and M. Pajouhi, “Association study of the −866G/A UCP2 gene promoter polymorphism with type 2 diabetes and obesity in a tehran population: a case control study,” Archives of Iranian Medicine, vol. 13, no. 5, pp. 384–390, 2010. View at Google Scholar · View at Scopus
  62. H. Nazem, M. A. Takhshid, S. M. B. Tabei, F. Sholevar, M. Entezam, and J. Manoochehri, “Investigation of association between serotonin transporter gene and type 2 diabetes mellitus,” Iranian Journal of Diabetes and Lipid Disorders, vol. 10, no. 1, pp. 84–89, 2010. View at Google Scholar
  63. J. T. Bazzaz, M. Shojapoor, H. Nazem et al., “Methylenetetrahydrofolate reductase gene polymorphism in diabetes and obesity,” Molecular Biology Reports, vol. 37, no. 1, pp. 105–109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Emamgholipour, A. Hossein-nezhad, A. Najmafshar, M. Rahmani, and B. Larijani, “Promoter resistin gene polymorphism in patients with type 2 diabetes and its influence on concerned metabolic phenotypes,” Iranian Journal of Diabetes and Lipid Disorders, vol. 8, no. 1, pp. 150–156, 2009. View at Google Scholar · View at Scopus
  65. S. Hasani-Ranjbar, P. Amiri, M. Namakchian et al., “Investigation of association between CXCL5 gene polymorphism and diabetes,” Iranian Journal of Diabetes and Lipid Disorders, vol. 8, no. 3, pp. 247–252, 2009. View at Google Scholar
  66. M. Kazemi Arababadi, A. A. Pourfathollah, S. Daneshmandi et al., “Evaluation of relation between IL-4 and IFN-γ polymorphisms and type 2 diabetes,” Iranian Journal of Basic Medical Sciences, vol. 12, no. 2, pp. 100–104, 2009. View at Google Scholar
  67. M. K. Arababadi, N. Naghavi, G. Hassanshahi, and M. Sajadi, “Evaluating the association of CCR5-d32 mutation with type 2 diabetes in Rafsanjanese patients,” Feyz Journal of Kashan University of Medical Sciences, vol. 13, no. 3, pp. 208–213, 2009. View at Google Scholar
  68. B. Kazemi, N. Seyed, E. Moslemi et al., “Insulin receptor gene mutations in Iranian patients with type II diabetes mellitus,” Iranian Biomedical Journal, vol. 13, no. 3, pp. 161–168, 2009. View at Google Scholar · View at Scopus
  69. H. Mirzaei, S. M. Akrami, T. Golmohammadi et al., “Polymorphism of Pro12Ala in the peroxisome proliferator-activated receptor 2 gene in Iranian diabetic and obese subjects,” Metabolic Syndrome and Related Disorders, vol. 7, no. 5, pp. 453–458, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. A. Nikzamir, M. Nakhjavani, T. Golmohammadi, L. Dibai, and R. Saffary, “Polymorphism in the angiotensin-converting enzyme (ACE) gene and ACE activity in type 2 diabetic patients,” Acta Medica Iranica, vol. 46, no. 4, pp. 277–282, 2008. View at Google Scholar
  71. F. Sharifi, A. Esmaeilzadeh, and M. Zali, “Hemochromatosis gene (HFE) mutations in patients with type 2 diabetes and their control group in an Iranian population,” Saudi Medical Journal, vol. 29, no. 6, pp. 808–812, 2008. View at Google Scholar · View at Scopus
  72. A. Besharati, S. M. Akrami, R. Heshmat, P. Yaghmaee, and B. Alirezapoor, “Investigation of association between apoAI gene polymorphisms and lipid profiles and type 2 diabetes mellitus in Iranian population,” Journal of Islamic Republic of Iran Medical Council, vol. 25, no. 2, pp. 132–141, 2007. View at Google Scholar
  73. S. Hasani-Ranjbar, J. Tavakkoly Bazzaz, P. Amiri, M. M. Amoli, and B. Larijani, “Investigation of the frequency of +45T/G polymorphism of adiponectin gene in type 2 diabetic patients in a Tehranian population,” Iranian Journal of Diabetes and Lipid Disorders, vol. 6, no. 3, pp. 215–218, 2007. View at Google Scholar
  74. R. Meshkani, M. Taghikhani, H. Al-Kateb et al., “Polymorphisms within the protein tyrosine phosphatase IB (PTPN1) gene promoter: functional characterization and association with type 2 diabetes and related metabolic traits,” Clinical Chemistry, vol. 53, no. 9, pp. 1585–1592, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. R. Meshkani, M. Taghikhani, B. Larijani et al., “Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPARγ-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population,” Clinical Chemistry and Laboratory Medicine, vol. 45, no. 4, pp. 477–482, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. F. Namvaran, M.-P. Rahimi, N. Azarpira, and M. H. Dabbaghmanesh, “Polymorphism of adiponectin (45T/G) and adiponectin receptor-2 (795G/A) in an iranian population: relation with insulin resistance and response to treatment with pioglitazone in patients with type 2 diabetes mellitus,” Molecular Biology Reports, vol. 39, no. 5, pp. 5511–5518, 2012. View at Publisher · View at Google Scholar · View at Scopus
  77. F. Namvaran, N. Azarpira, P. Rahimi-Moghaddam, and M. H. Dabbaghmanesh, “Polymorphism of peroxisome proliferator-activated receptor γ (PPARγ) Pro12Ala in the Iranian population: Relation with insulin resistance and response to treatment with pioglitazone in type 2 diabetes,” European Journal of Pharmacology, vol. 671, no. 1–3, pp. 1–6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Hossein-nezhad, K. Mirzaei, P. Shabani et al., “Association of VDR gene polymorphism with insulin resistance in diabetic patient's running title: VDR and insulin resistance,” Iranian Journal of Diabetes and Lipid Disorders, vol. 8, no. 1, pp. 143–149, 2009. View at Google Scholar · View at Scopus
  79. A. Moosapoor, M. Taghikhani, R. Meshkani, S. Khatami, S. Bakhtiari, and K. Haghani, “Association of 3′UTR (1484insG) polymorphism of PTP1B gene with Type 2 diabetes, in-sulin resistance and obesity in a Tehranian population,” Journal of School of Public Health and Institute of Public Health Research, vol. 5, no. 3, pp. 1–13, 2007. View at Google Scholar
  80. R. Bayatmakoo, H. Mobaiyen, A. Monfaredan, K. B. Sofiani, and R. Benissy, “The study of effects common paraoxonase polymorphism (L55M) on atherosclerosis risk in diabetic patients by PCR-RFLP,” European Journal of Experimental Biology, vol. 3, no. 3, pp. 512–516, 2013. View at Google Scholar
  81. R. Bayatmakoo, A. Monfaredan, N. Bargahi, H. Mobaiyen, and N. Aslanabadi, “Paraoxonase gene polymorphism and atherosclerosis risk in diabetic patients,” Journal of Azad University of Medical Sciences, vol. 22, no. 3, pp. 191–197, 2012. View at Google Scholar
  82. A. Esteghamati, N. Mansournia, M. Nakhjavani, M. A. Mansournia, A. Nikzamir, and M. Abbasi, “Association of +45(T/G) and +276(G/T) polymorphisms in the adiponectin gene with coronary artery disease in a population of Iranian patients with type 2 diabetes,” Molecular Biology Reports, vol. 39, no. 4, pp. 3791–3797, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. Z. Rahimi, R. Nourozi-Rad, and A. Parsian, “Strong interaction between T allele of endothelial nitric oxide synthase with B1 allele of cholesteryl ester transfer protein TaqIB highly elevates the risk of coronary artery disease and type 2 diabetes mellitus,” Human Genomics, vol. 6, article 20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. A. Assali, M. Ghayour-Mobarhan, A. Sahebkar et al., “Association of angiotensin II type 1 receptor gene A1166C polymorphism with the presence of diabetes mellitus and metabolic syndrome in patients with documented coronary artery disease,” European Journal of Internal Medicine, vol. 22, no. 3, pp. 254–261, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Emamgholipour, A. Hossein-nezhad, S. A. Mohajerani, M. Shirzad, and B. Larijani, “Association between promoter resistin gene polymorphism and coronary artery disease in diabetic and non diabetic patients,” Iranian Journal of Diabetes and Lipid Disorders, vol. 10, no. 2, pp. 221–228, 2009. View at Google Scholar
  86. S. Fallah, M. Seifi, and A. Samadikuchaksaraei, “Risk of coronary artery stenosis in Iranian type 2 diabetics: is there a role for matrix metalloproteinase-3 gene (-1612 5A/6A) polymorphism?” Journal of Physiology and Biochemistry, vol. 66, no. 4, pp. 359–364, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Vaisi-Raygani, Z. Rahimi, H. Tavilani, and T. Pourmotabbed, “Butyrylcholinesterase K variant and the APOE-epsilon 4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients,” Molecular Biology Reports, vol. 37, no. 4, pp. 2083–2091, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. Z. Rahimi, H. Nomani, H. Mozafari et al., “Factor v G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran,” Blood Coagulation & Fibrinolysis, vol. 20, no. 4, pp. 252–256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. M. Nakhjavani, F. Esfahanian, A. Jahanshahi et al., “The relationship between the insertion/deletion polymorphism of the ACE gene and hypertension in Iranian patients with type 2 diabetes,” Nephrology Dialysis Transplantation, vol. 22, no. 9, pp. 2549–2553, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. A. Vaisi-Raygani, Z. Rahimi, H. Nomani, H. Tavilani, and T. Pourmotabbed, “The presence of apolipoprotein ε4 and ε2 alleles augments the risk of coronary artery disease in type 2 diabetic patients,” Clinical Biochemistry, vol. 40, no. 15, pp. 1150–1156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. Z. Rahimi, F. Shahvaisi-Zadeh, S. Sadeghei, M. Vessal, and N. Yavari, “eNOS 4a/b polymorphism and its interaction with eNOS G894T variants in type 2 diabetes mellitus: modifying the risk of diabetic nephropathy,” Disease Markers, vol. 34, no. 6, pp. 437–443, 2013. View at Publisher · View at Google Scholar · View at Scopus
  92. Z. Rahimi, O. Mansouri Zaveleh, Z. Rahimi, and A. Abbasi, “AT2R -1332 G:A polymorphism and diabetic nephropathy in type 2 diabetes mellitus patients,” Journal of Renal Injury Prevention, vol. 2, no. 3, pp. 97–101, 2013. View at Publisher · View at Google Scholar
  93. F. Shahsavar, A. Kheirollahi, M. Jafarzadeh, and M. hedayati, “SUMO4 M55V Polymorphism is associated with diabetic nephropathy in Iranian type 2 diabetes patients,” Life Science Journal, vol. 10, no. 5, pp. 485–487, 2013. View at Google Scholar · View at Scopus
  94. M. K. Arababadi, M. R. Mirzaei, S. M. A. Sajadi et al., “Interleukin (IL)-10 gene polymorphisms are associated with type 2 diabetes with and without nephropathy: a study of patients from the Southeast Region of Iran,” Inflammation, vol. 35, no. 3, pp. 797–802, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. A. Nikzamir, A. Esteghamati, A. A. Hammedian, and T. Mahmoudi, “The role of vascular endothelial growth factor +405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus,” Molecular Biology Reports, vol. 39, no. 2, pp. 881–886, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. Z. Rahimi, A. Hasanvand, and V. Felehgari, “Interaction of MTHFR 1298C with ACE D allele augments the risk of diabetic nephropathy in Western Iran,” DNA and Cell Biology, vol. 31, no. 4, pp. 553–559, 2012. View at Publisher · View at Google Scholar · View at Scopus
  97. Z. Rahimi, A. Vaisi-Raygani, and A. Parsian, “Concomitant presence of endothelial nitric oxide 894T and angiotensin II-converting enzyme D alleles are associated with diabetic nephropathy in a Kurdish population from Western Iran,” Nephrology (Carlton, Vic), vol. 17, no. 2, pp. 175–181, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. V. Felehgari, Z. Rahimi, H. Mozafari, and A. Vaisi-Raygani, “ACE gene polymorphism and serum ACE activity in Iranians type II diabetic patients with macroalbuminuria,” Molecular and Cellular Biochemistry, vol. 346, no. 1-2, pp. 23–30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. Y. Jafari, Z. Rahimi, A. Vaisi-Raygani, and M. Rezaei, “Interaction of eNOS polymorphism with MTHFR variants increase the risk of diabetic nephropathy and its progression in type 2 diabetes mellitus patients,” Molecular and Cellular Biochemistry, vol. 353, no. 1-2, pp. 23–34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  100. Z. Rahimi, V. Felehgari, M. Rahimi et al., “The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria,” Molecular Biology Reports, vol. 38, no. 3, pp. 2117–2123, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. M. K. Arababadi, “Interleukin-4 gene polymorphisms in type 2 diabetic patients with nephropathy,” Iranian Journal of Kidney Diseases, vol. 4, no. 4, pp. 302–306, 2010. View at Google Scholar · View at Scopus
  102. R. Nosratabadi, M. K. Arababadi, V. A. Salehabad et al., “Polymorphisms within exon 9 but not intron 8 of the vitamin D receptor are associated with the nephropathic complication of type-2 diabetes,” International Journal of Immunogenetics, vol. 37, no. 6, pp. 493–497, 2010. View at Publisher · View at Google Scholar · View at Scopus
  103. M. Rahimi, A. Hasanvand, Z. Rahimi et al., “Synergistic effects of the MTHFR C677T and A1298C polymorphisms on the increased risk of micro- and macro-albuminuria and progression of diabetic nephropathy among Iranians with type 2 diabetes mellitus,” Clinical Biochemistry, vol. 43, no. 16-17, pp. 1333–1339, 2010. View at Publisher · View at Google Scholar · View at Scopus
  104. A. Nikzamir, A. Esteghamati, M. Feghhi, M. Nakhjavani, A. Rashidi, and J. Z. Reza, “The insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with progression, but not development, of albuminuria in Iranian patients with type 2 diabetes,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 10, no. 2, pp. 109–114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. A. R. Nikzamir, T. Golmohammadi, M. Nakhjavani, M. Zahraei, and A. A. Amirzargar, “Angiotensin converting enzyme gene polymorphism in Iranian patients with type 2 diabetes,” Iranian Journal of Immunology, vol. 3, no. 1, pp. 23–29, 2006. View at Google Scholar · View at Scopus
  106. N. Abbasi, Z. Salehi, and Y. Alizadeh, “Analysis of glutathione S-transferase M1 (GSTM1) deletion in diabetic retinopathy,” Journal of Guilan University of Medical Sciences, vol. 88, pp. 34–40, 2013. View at Google Scholar
  107. A. Dadbinpour, M. Sheikhha, M. Darbouy, and M. Afkhami-Ardekani, “Investigating GSTT1 and GSTM1 null genotype as the risk factor of diabetes type 2 retinopathy,” Journal of Diabetes & Metabolic Disorders, vol. 12, no. 1, pp. 48–53, 2013. View at Publisher · View at Google Scholar
  108. M. Feghhi, A. Nikzamir, A. Esteghamati, T. Mahmoudi, and M. S. Yekaninejad, “Relationship of vascular endothelial growth factor (VEGF) +405 G/C polymorphism and proliferative retinopathy in patients with type 2 diabetes,” Translational Research, vol. 158, no. 2, pp. 85–91, 2011. View at Google Scholar
  109. M. M. Amoli, S. Hasani-Ranjbar, N. Roohipour et al., “VEGF gene polymorphism association with diabetic foot ulcer,” Diabetes Research and Clinical Practice, vol. 93, no. 2, pp. 215–219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  110. H. Chu, M. Wang, D. Zhong et al., “AdipoQ polymorphisms are associated with type 2 diabetes mellitus: a meta-analysis study,” Diabetes/Metabolism Research and Reviews, vol. 29, no. 7, pp. 532–545, 2013. View at Publisher · View at Google Scholar · View at Scopus
  111. J. Wang, J. Zhang, L. Li et al., “Association of rs12255372 in the TCF7L2 gene with type 2 diabetes mellitus: a meta-analysis,” Brazilian Journal of Medical and Biological Research, vol. 46, no. 4, pp. 382–393, 2013. View at Publisher · View at Google Scholar · View at Scopus
  112. M. Saadat, “Null genotypes of glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms increased susceptibility to type 2 diabetes mellitus, a meta-analysis,” Gene, vol. 532, no. 1, pp. 160–162, 2013. View at Publisher · View at Google Scholar · View at Scopus
  113. S.-T. Tang, C.-J. Wang, H.-Q. Tang, Q. Zhang, and Y. Wang, “Evaluation of glutathione S-transferase genetic variants affecting type 2 diabetes susceptibility: a meta-analysis,” Gene, vol. 530, no. 2, pp. 301–308, 2013. View at Publisher · View at Google Scholar · View at Scopus
  114. J.-H. Zhong, A. C. Rodríguez, N.-N. Yang, and L.-Q. Li, “Methylenetetrahydrofolate reductase gene polymorphism and risk of type 2 diabetes mellitus,” PLoS ONE, vol. 8, no. 9, Article ID e74521, 2013. View at Publisher · View at Google Scholar · View at Scopus
  115. S. Yang, J. Zhang, C. Feng, and G. Huang, “MTHFR 677 T variant contributes to diabetic nephropathy risk in Caucasian individuals with type 2 diabetes: a meta-analysis,” Metabolism: Clinical and Experimental, vol. 62, no. 4, pp. 586–594, 2013. View at Publisher · View at Google Scholar · View at Scopus
  116. Y. Hua, J. Shen, Y. Song, Y. Xing, and X. Ye, “Interleukin-10 −2592C/A, −2819C/T and −21082A/G polymorphisms with risk of type 2 diabetes mellitus: a HuGE review and meta-analysis,” PLoS ONE, vol. 8, no. 6, Article ID e66568, 2013. View at Publisher · View at Google Scholar
  117. M. A.-H. Helaly, E.-S. Z. Hatata, M. Abu-Elmagd et al., “Association of IL-10 and IL-6 gene polymorphisms with type 2 diabetes mellitus among Egyptian patients,” European Journal of General Medicine, vol. 10, no. 3, pp. 158–162, 2013. View at Google Scholar · View at Scopus
  118. S. Vats, V. Sambyal, and A. J. S. Bhanwer, “Genetic links between coronary artery disease and type 2 diabetes,” Human Biology Review, vol. 2, no. 2, pp. 90–119, 2013. View at Google Scholar
  119. G. Wang, Q. Zhang, N. Xu et al., “Associations between two polymorphisms (FokI and BsmI) of vitamin D receptor gene and type 1 diabetes mellitus in Asian population: a meta-analysis,” PLoS ONE, vol. 9, no. 3, Article ID e89325, 2014. View at Publisher · View at Google Scholar · View at Scopus
  120. K. Tizaoui, W. Kaabachi, A. Hamzaoui, and K. Hamzaoui, “Contribution of VDR polymorphisms to type 1 diabetes susceptibility: systematic review of case-control studies and meta-analysis,” Journal of Steroid Biochemistry and Molecular Biology, vol. 143, pp. 240–249, 2014. View at Publisher · View at Google Scholar · View at Scopus
  121. L. Sun, Q. Yuan, N. Cao et al., “VEGF genetic polymorphisms may contribute to the risk of diabetic nephropathy in patients with diabetes mellitus: a meta-analysis,” The Scientific World Journal, vol. 2014, Article ID 624573, 11 pages, 2014. View at Publisher · View at Google Scholar
  122. B. S. Dellamea, L. C. F. Pinto, C. B. Leitão, K. G. Santos, and L. H. S. Canani, “Endothelial nitric oxide synthase gene polymorphisms and risk of diabetic nephropathy: a systematic review and meta-analysis,” BMC Medical Genetics, vol. 15, article 9, 2014. View at Publisher · View at Google Scholar · View at Scopus
  123. Z. J. Ma, R. Chen, H.-Z. Ren, X. Guo, J. G. Chen, and L.-M. Chen, “Endothelial nitric oxide synthase (eNOS) 4b/a polymorphism and the risk of diabetic nephropathy in type 2 diabetes mellitus: a meta-analysis,” Meta Gene, vol. 2, no. 1, pp. 50–62, 2014. View at Publisher · View at Google Scholar · View at Scopus
  124. M. G. Ehm, M. C. Karnoub, H. Sakul et al., “Genomewide search for type 2 diabetes susceptibility genes in four american population,” The American Journal of Human Genetics, vol. 66, no. 6, pp. 1871–1881, 2000. View at Publisher · View at Google Scholar · View at Scopus
  125. F. Busfield, D. L. Duffy, J. B. Kesting et al., “A genomewide search for type 2 diabetes-susceptibility genes in indigenous Australians,” American Journal of Human Genetics, vol. 70, no. 2, pp. 349–357, 2002. View at Publisher · View at Google Scholar · View at Scopus
  126. S. C. Elbein, M. D. Hoffman, K. Teng, M. F. Leppert, and S. J. Hasstedt, “A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians,” Diabetes, vol. 48, no. 5, pp. 1175–1182, 1999. View at Publisher · View at Google Scholar · View at Scopus
  127. C. N. Rotimi, G. Chen, A. A. Adeyemo et al., “A genome-wide search for type 2 diabetes susceptibility genes in West Africans,” Diabetes, vol. 53, no. 3, pp. 838–841, 2004. View at Publisher · View at Google Scholar
  128. S. Cauchi, D. Meyre, E. Durand et al., “Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value,” PLoS ONE, vol. 3, no. 5, Article ID e2031, 2008. View at Publisher · View at Google Scholar · View at Scopus